Prenatal diagnosis of beta-thalassaemia in Pakistan: Experience in a Muslim country

Prenatal Diagnosis

Volumn 20, Issue 5, 2000, Pages 378-383

  Ahmed, Suhaib ^a   Saleem, Mohammad ^a   Sultana, Nadra ^b   Raashid, Yasmeen ^c   Waqar, Amin ^a   Anwar, Masood ^a   Modell, Bernadette ^d   Karamat, Karamat A ^a   Petrou, Mary ^d  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b Military Hospital   (Pakistan)

^c Lady Wellington Hospital   (Pakistan)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Pakistan; Prenatal diagnosis; Thalassaemia

Indexed keywords

DNA;

ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FETUS; GENE AMPLIFICATION; GENETIC COUNSELING; GENETIC LINKAGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOSLEM; PAKISTAN; PATIENT ATTITUDE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

ATTITUDE; BETA-THALASSEMIA; CHORIONIC VILLI SAMPLING; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GESTATIONAL AGE; HUMANS; ISLAM; PAKISTAN; PATIENT EDUCATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0034064855     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(200005)20:5<378::AID-PD815>3.0.CO;2-7     Document Type: Article

References (13)

1. Ahmed S, Petrou M, Saleem M. 1996. Molecular genetics of β-thalassaemia in Pakistan: a basis for prenatal diagnosis. Br J Haematol 94: 476-482.
2. Alwan AA, Modell B. 1997. Community Control of Genetic and Congenital Disorders. EMRO Technical Publication Series 24. WHO regional office for the Eastern Mediterranean Region. ISBN 92-9021-220-9ISSN 1020-0428.
3. Cai SP, Kan YW. 1990. Identification of the multiple β-thalassaemia mutations by denaturing gradient gel electrophoresis. J Clin Invest 85: 550-553.
4. Cai SP, Wall J, Dan YW, Chehab FF. 1994. Reverse dot blot probes for the screening of β-thalassaemia mutations in Asians and American Blacks. Hum Mut 3: 59-63.
5. Cao A. 1987. Results of programmes for antenatal detection of thalassaemia in reducing the incidence of the disorder. Blood Rev 1: 169-176.
6. Higuchi R, Kwok S. 1989. Avoiding false positives with PCR. Nature 339: 237-238.
7. Maggio A, Giambona A, Cai SP, Wall J, Kan YW, Chehab FF. 1993. Rapid and simultaneous typing of haemoglobin S, haemoglobin C, and seven Mediterranean β-thalassaemia mutations by covalent reverse dot blot analysis: application to prenatal diagnosis in Sicily. Blood 81: 239-242.
8. Makdur MS. 1974. Sterilisation and abortion from the point of view of Islam. In Islam and Family Planning, Nazer IR, Karmi HS, Zayid MY, (eds). Beruit: Imprimerie Catholique, 263.
9. Petrou M. 1994. The UK control programme for the haemoglobin disorders. Fetal Maternal Med Rev 6: 191-201.
10. Petrou M, Modell B. 1995. Prenatal screening for haemoglobin disorders. Prenat Diagn 15: 1275-1295.
11. Petrou M, Modell M, Darr A, Old JM, Kin E, Weatherall DJ. 1990. Antenatal diagnosis: how to deliver a comprehensive service in the United Kingdom. Ann NY Acad Sci 612: 251-263.
12. Saxena R, Jain PK, Thomas E, Verma jC. 1998. Prenatal diagnosis of beta-thalassaemia: experience in a developing country. Prenat Diag 18: 1-7.
13. Varawalla NY, Fitchies AC, Old JM. 1992. Analysis of β-globin haplotypes in Asian Indians: origin and spread of β-thalassaemia on the Indian subcontinent. Hum Genet 90: 443-449.